Equibles does not estimate personal net worth.
Get an email with a short summary when Phibro Animal Health Corp publishes a filing, an earnings call transcript or a press release.
Get PAHC alertsLarry L. Miller is recorded as COO at Phibro Animal Health Corp (PAHC). The newest filing on record that lists Larry L. Miller as COO at Phibro Animal Health Corp (PAHC) is dated September 16, 2022. The proxy statement of Phibro Animal Health Corp reports total compensation of $998,821 for Larry L. Miller in fiscal 2022, including a base salary of $634,995. Disclosed compensation is on record for 5 fiscal years. Larry L. Miller has spoken on 6 earnings calls and 3 other investor events across 1 company, most recently for Phibro Animal Health Corp on November 5, 2026. Phibro Animal Health Corp is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Phibro Animal Health Corp includes Daniel (Dani) Bendheim (CEO), Gerald K. Carlson (CEO and Board Member), Carol A. Wrenn (Chairman) and 7 others.
“First, you know, what we've seen so far and then kind of what we expect to see and what some of the projections are going forward as we finish out, as the industry finishes out 2026 and into 2027.”
“So we're coming out of a period of really unprecedented profitability and growth for both the protein sector across all species, but also profitability has been very good underlying for our producers of protein.”
“So again, we're investing in this portfolio. Again, the medicated feed ad has been complemented with the nutrition specialties and vaccines. As you know, you know, the market demand and the meat sector and the dairy sector continue to be in good state with good underlying demand.”
“It's great to be here, and thank you for taking your time to spend it with us this morning. Before we begin, I just want to draw your attention to our safe harbor statement.”
“Specie, we're nicely diversified, particularly after the acquisition now. Now, by specie, we're much more balanced, and by geographic area, also stronger and more balanced.”
Start not stated–present
Last confirmed September 16, 2022
Drug Manufacturers - Specialty & Generic · Healthcare
COO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Phibro Animal Health Corp (PAHC) | Chief Operating Officer | $634,995 | $998,821 |
| 2021 | Phibro Animal Health Corp (PAHC) | Chief Operating Officer | $618,000 | $1,074,174 |
| 2020 | Phibro Animal Health Corp (PAHC) | Chief Operating Officer | $618,000 | $819,305 |
| 2019 | Phibro Animal Health Corp (PAHC) | Chief Operating Officer | $600,000 | $670,563 |
| 2018 | Phibro Animal Health Corp (PAHC) | Chief Operating Officer | $566,500 | $6,864,057 |
